1. Home
  2. SLNO vs VSEC Comparison

SLNO vs VSEC Comparison

Compare SLNO & VSEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • VSEC
  • Stock Information
  • Founded
  • SLNO 1999
  • VSEC 1959
  • Country
  • SLNO United States
  • VSEC United States
  • Employees
  • SLNO N/A
  • VSEC N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VSEC Military/Government/Technical
  • Sector
  • SLNO Health Care
  • VSEC Consumer Discretionary
  • Exchange
  • SLNO Nasdaq
  • VSEC Nasdaq
  • Market Cap
  • SLNO 3.8B
  • VSEC 3.2B
  • IPO Year
  • SLNO 2014
  • VSEC N/A
  • Fundamental
  • Price
  • SLNO $52.75
  • VSEC $164.45
  • Analyst Decision
  • SLNO Strong Buy
  • VSEC Strong Buy
  • Analyst Count
  • SLNO 10
  • VSEC 4
  • Target Price
  • SLNO $112.50
  • VSEC $145.00
  • AVG Volume (30 Days)
  • SLNO 1.9M
  • VSEC 208.4K
  • Earning Date
  • SLNO 11-05-2025
  • VSEC 11-04-2025
  • Dividend Yield
  • SLNO N/A
  • VSEC 0.24%
  • EPS Growth
  • SLNO N/A
  • VSEC 31.62
  • EPS
  • SLNO N/A
  • VSEC 0.95
  • Revenue
  • SLNO $32,656,999.00
  • VSEC $1,253,105,000.00
  • Revenue This Year
  • SLNO N/A
  • VSEC $2.95
  • Revenue Next Year
  • SLNO $175.39
  • VSEC $14.66
  • P/E Ratio
  • SLNO N/A
  • VSEC $52.42
  • Revenue Growth
  • SLNO N/A
  • VSEC 52.47
  • 52 Week Low
  • SLNO $41.50
  • VSEC $80.60
  • 52 Week High
  • SLNO $90.32
  • VSEC $169.78
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 24.40
  • VSEC 56.42
  • Support Level
  • SLNO $50.63
  • VSEC $160.00
  • Resistance Level
  • SLNO $72.99
  • VSEC $169.63
  • Average True Range (ATR)
  • SLNO 4.32
  • VSEC 4.54
  • MACD
  • SLNO -1.06
  • VSEC -0.77
  • Stochastic Oscillator
  • SLNO 9.34
  • VSEC 58.43

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.

Share on Social Networks: